ANTHRACYCLINE ANTIBIOTIC/TOPOISOMERASE INHIBITOR
Idamycin, also known by its drug name, Idarubicin, is a prescription medication approved by the Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in adults. Idamycin is often combined with other drugs such as Cytarabine in specific chemotherapy regimens.
Idamycin is an anticancer drug used in chemotherapy. Idamycin is a member of a drug class called anthracycline antibiotics. Idamycin is also a topoisomerase inhibitor. Idamycin is believed to work by damaging DNA and blocking cell division in several different ways.
How do I take it?
Idamycin is administered as an intravenous infusion during chemotherapy treatment.
The FDA-approved label for Idamycin lists common side effects including frequent infections, hair loss, nausea, vomiting, diarrhea, abdominal cramps, mouth sores, and abnormal bleeding.
Rare but serious side effects listed for Idamycin include heart failure, severe damage to skin at injection sites, and fetal harm in pregnant women.
For more details about this treatment, visit:
Idamycin – Pfizer
AML: Chemotherapy and Drug Therapy – Leukemia & Lymphoma Society